Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis
Аннотация
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Advanced NanoBiomed Research, EarlyView.
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...
MedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.